Krilogy Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.89M Buy
2,474
+596
+32% +$450K 0.05% 273
2026
Q2
$1.17M Sell
1,878
-565
-23% -$385K 0.03% 343
2026
Q1
$1.82M Sell
2,443
-33
-1% -$25.3K 0.06% 235
2025
Q4
$1.89M Buy
2,476
+385
+18% +$261K 0.06% 222
2025
Q3
$1.35M Buy
+2,091
New +$1.18M 0.05% 265

Other funds holding REGN

Krilogy Financial's REGN Position: Q3 2026 in Review

Krilogy Financial increased its Regeneron Pharmaceuticals (REGN) stake by 32% in Q3 2026, buying an estimated $450K and bringing the position to 2,474 shares worth $1.89M. The position accounts for 0.05% of the portfolio, ranked #273.

Krilogy Financial first reported a position in REGN in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.89M in Q4 2025. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Krilogy Financial held 2,474 shares of Regeneron Pharmaceuticals worth $1.89M as of Q3 2026.
  • Krilogy Financial bought 596 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $450K.
  • Regeneron Pharmaceuticals made up 0.05% of Krilogy Financial's portfolio in Q3 2026, its #273 holding.
  • Krilogy Financial first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Krilogy Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2025.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.